{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:38:55Z","timestamp":1784687935290,"version":"3.55.0"},"reference-count":41,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Michael E. DeBakey VA Medical Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Most patients with pancreatic cancer at some point present with symptoms related to exocrine pancreatic insufficiency (EPI). These include diarrhea, abdominal bloating, indigestion, steatorrhea, weight loss, and anorexia. Even though up to 80% of pancreatic cancer patients eventually present with symptoms related to exocrine pancreatic insufficiency, only 21% are prescribed pancreatic enzyme replacement therapy (PERT). Its effectiveness is also highly dependent on its proper timing of administration, and patients must be thoroughly educated about this. The impact of symptoms of EPI can lead to poorer overall well-being. Pharmacists play a crucial role in properly educating patients on the correct use of pancreatic enzyme replacement therapy. PERT is a key strategy in managing the symptoms of EPI and can improve quality of life, which is a central focus in palliative care. This treatment is profoundly underutilized in the palliative care of these patients. The objective of this review is to discuss the pharmacology, pharmacokinetics, side effects, available evidence of the effectiveness of pancreatic enzyme use for patients with pancreatic cancer, and challenges, along with proposed solutions regarding its use.<\/jats:p>","DOI":"10.3390\/pharmacy12020047","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T04:03:50Z","timestamp":1709697830000},"page":"47","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rational Prescribing of Pancreatic Enzymes for Patients with Pancreatic Cancer"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6627-2697","authenticated-orcid":false,"given":"Mary Acelle G.","family":"Garcia","sequence":"first","affiliation":[{"name":"Rehabilitation & Extended Care Line, Section of Palliative Medicine, Michael E DeBakey Veteran Affairs Medical Center, Houston, TX 77030, USA"},{"name":"Department of Medicine, Section of Geriatric and Palliative Medicine, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Imam","sequence":"additional","affiliation":[{"name":"Rehabilitation & Extended Care Line, Section of Palliative Medicine, Michael E DeBakey Veteran Affairs Medical Center, Houston, TX 77030, USA"},{"name":"Department of Medicine, Section of Geriatric and Palliative Medicine, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula K.","family":"Braun","sequence":"additional","affiliation":[{"name":"Rehabilitation & Extended Care Line, Section of Palliative Medicine, Michael E DeBakey Veteran Affairs Medical Center, Houston, TX 77030, USA"},{"name":"Department of Medicine, Section of Geriatric and Palliative Medicine, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne K.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Rehabilitation & Extended Care Line, Section of Palliative Medicine, Michael E DeBakey Veteran Affairs Medical Center, Houston, TX 77030, USA"},{"name":"Department of Medicine, Section of Geriatric and Palliative Medicine, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer Statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Vujasinovic, M., Valente, R., Del Chiaro, M., Permert, J., and L\u00f6hr, J.-M. (2017). Pancreatic Exocrine Insufficiency in Pancreatic Cancer. Nutrients, 9.","DOI":"10.3390\/nu9030183"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02712816","article-title":"Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage","volume":"7","author":"Porta","year":"2005","journal-title":"Clin. Transl. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.pan.2020.03.020","article-title":"The assessment of pancreatic exocrine function in patients with inoperable pancreatic cancer: In need of a new gold-standard","volume":"20","author":"Carnie","year":"2020","journal-title":"Pancreatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/MCG.0b013e31829f56e7","article-title":"a prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor","volume":"48","author":"Sikkens","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejso.2020.03.006","article-title":"Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer","volume":"47","author":"Carino","year":"2021","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/gut.39.4.580","article-title":"Faecal elastase 1: A novel, highly sensitive, and specific tubeless pancreatic function test","volume":"39","author":"Loser","year":"1996","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11592990-000000000-00000","article-title":"Administration of CREON\u00ae pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: An in vitro study","volume":"31","author":"Shlieout","year":"2011","journal-title":"Clin. Drug Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40271-017-0233-0","article-title":"Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument","volume":"10","author":"Johnson","year":"2017","journal-title":"Patient Cent. Outcomes Res."},{"key":"ref_10","first-page":"1335","article-title":"Pancreatic Enzyme Replacement Therapy and Nutritional Advice are Associated with Longer Survival in Patients with Unresectable Pancreatic Cancer","volume":"42","author":"Nieto","year":"2013","journal-title":"Pancreas"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00520-013-1729-3","article-title":"Pancreatic cancer and supportive care\u2014Pancreatic exocrine insufficiency negatively impacts on quality of life","volume":"21","author":"Gooden","year":"2013","journal-title":"Support Care Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pan.2018.10.010","article-title":"Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study","volume":"19","author":"Roberts","year":"2019","journal-title":"Pancreatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"807632","DOI":"10.3389\/fphys.2022.807632","article-title":"Pancreas\u2014Its Functions, Disorders, and Physiological Impact on the Mammals\u2019 Organism","volume":"13","author":"Czauderna","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_14","unstructured":"Food and Drug Administration (2023, November 02). Creon, Available online: https:\/\/www.accessdata.fda.gov.creon."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/clinchem\/42.2.222","article-title":"Immunoreactive elastase I: Clinical evaluation of a new noninvasive test of pancreatic function","volume":"42","author":"Stein","year":"1996","journal-title":"Clin. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fphys.2020.00008","article-title":"Multiparametric mapping magnetic resonance imaging of pancreatic disease","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3748\/wjg.v21.i1.262","article-title":"Long-term survival after resection of pancreatic cancer: A single-center retrospective analysis","volume":"21","author":"Yamamoto","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/CE.S26705","article-title":"Pancrelipase: An evidence-based review of its use for treating pancreatic exocrine insufficiency","volume":"7","author":"Nakajima","year":"2012","journal-title":"Core Evid."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bpg.2010.03.008","article-title":"Diagnosis of chronic pancreatitis: Functional testing","volume":"24","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2016.67.5561","article-title":"Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Balaban","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_21","unstructured":"Trevor, A.J., Katzung, B.G., Kruidering-Hall, M.M., and Masters, S.B. (2013). Katzung & Trevor\u2019s Pharmacology: Examination & Board Review, 10e, McGraw Hill. Available online: https:\/\/accesspharmacy.mhmedical.com\/content.aspx?bookid=514\u00a7ionid=41817558."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0884533611405537","article-title":"Pancreatic enzyme supplementation for patients receiving enteral feeds","volume":"26","author":"Ferrie","year":"2011","journal-title":"Nutr. Clin. Pract."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gut.42.1.92","article-title":"Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region","volume":"42","author":"Bruno","year":"1998","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/MPA.0000000000001330","article-title":"Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients","volume":"48","author":"Barkin","year":"2019","journal-title":"Pancreas"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MPA.0000000000000767","article-title":"The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer: A Prospective Cohort Study","volume":"46","author":"Saito","year":"2017","journal-title":"Pancreas"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Struyvenberg, M.R., Martin, C.R., and Freedman, S.D. (2017). Practical guide to exocrine pancreatic insufficiency\u2014Breaking the myths. BMC Med., 15.","DOI":"10.1186\/s12916-017-0783-y"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000319411","article-title":"Pancreatic exocrine insufficiency: Diagnostic evaluation and replacement therapy with pancreatic enzymes","volume":"28","author":"Hammer","year":"2010","journal-title":"Dig. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM199705013361803","article-title":"High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis","volume":"336","author":"FitzSimmons","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004836-199507000-00001","article-title":"Cystic fibrosis and colonic strictures. A new \u201ciatrogenic\u201d disease","volume":"21","year":"1995","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3476(95)70153-2","article-title":"Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy","volume":"127","author":"Borowitz","year":"1995","journal-title":"J. Pediatr."},{"key":"ref_31","unstructured":"The Clatterbridge Cancer Centre, and NHS Foundation Trust (2023, October 20). Pancreatic Enzyme Replacement Therapy (PERT) Guidance. Available online: https:\/\/www.clatterbridgecc.nhs.uk\/application\/files\/3914\/3504\/9642\/PancreaticEnzymeReplacementTherapyPERTGuidanceV1.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcf.2009.08.008","article-title":"Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis","volume":"8","author":"Trapnell","year":"2009","journal-title":"J. Cyst. Fibros"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1365-2036.2005.02390.x","article-title":"Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: A randomized, three-way crossover study","volume":"21","author":"Figueiras","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jpainsymman.2022.04.158","article-title":"Appropriate use of pancreatic enzymes in veterans with pancreatic cancer","volume":"63","author":"Garcia","year":"2022","journal-title":"J. Pain Symptom Manag."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1136\/bmjspcare-2019-002153","article-title":"Enzyme replacement in advanced pancreatic cancer: Patient perceptions","volume":"13","author":"Landers","year":"2023","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_36","first-page":"1120","article-title":"Pharmacist roles in the medication use process: Perceptions of patients, physicains and pharmacists","volume":"63","author":"Kim","year":"2023","journal-title":"JAPhA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1200\/JCO.2021.39.3_suppl.401","article-title":"Projected 30-day out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D","volume":"39","author":"Gupta","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2016.67.1412","article-title":"Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Sohal","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cgh.2007.01.004","article-title":"13C-Mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis","volume":"5","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ca\u00f1amares-Orb\u00eds, P., Garc\u00eda-Rayado, G., and Alfaro-Almajano, E. (2022). Nutritional Support in Pancreatic Diseases. Nutrients, 14.","DOI":"10.3390\/nu14214570"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/10781552211038031","article-title":"Case report: Proton pump inhibitor drug-related problem in pancreatic cancer patient unmasks pancreatic enzyme insufficiency","volume":"28","author":"Giani","year":"2021","journal-title":"J. Oncol. Pharm. Pract."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/2\/47\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:09:45Z","timestamp":1760105385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/2\/47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["pharmacy12020047"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy12020047","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]}}}